Press Release Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO CHENGDU, China, Oct. 20, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the… CISION PRNewswireOctober 20, 2025
Press Release MILESEEY GenePro G1 Named to TIME's "The Best Inventions of 2025: Special Mentions" The first "GPS + Laser" hybrid rangefinder redefining how golfers see and… CISION PRNewswireOctober 20, 2025
Press Release Chengdu CATANIA's Tower 2 Debuts Globally: A 222-Meter-High Sky Residence Redefining Global Luxury Living. CHENGDU, China, Oct. 20, 2025 /PRNewswire/ — A news report from CNS:… CISION PRNewswireOctober 20, 2025
Biparatopic HER2-targeting ADC JSKN003 Was Granted Another Breakthrough Therapy Designation for HER2-Positive Advanced Colorectal Cancer SUZHOU, China, Oct. 20, 2025 /PRNewswire/ — October 20, 2025- Alphamab Oncology (stock… CISION PRNewswireOctober 20, 2025
Alphamab Oncology Presented Multiple Clinical Data on Biparatopic HER2-targeting ADC JSKN003 at ESMO Congress 2025 SUZHOU, China, Oct. 20, 2025 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK)… CISION PRNewswireOctober 20, 2025
Zeekr Group to Report Third Quarter 2025 Financial Results on November 17, 2025 HANGZHOU, China, Oct. 20, 2025 /PRNewswire/ — ZEEKR Intelligent Technology Holding Limited… CISION PRNewswireOctober 20, 2025
Global Times 'Overseas China Week' photo exhibition in Seoul highlights China-South Korea friendship and exchanges BEIJING, Oct. 20, 2025 /PRNewswire/ — The Global Times’ "Overseas China Week"… CISION PRNewswireOctober 20, 2025
Press Release Press Conference for 2025 World Internet Conference Wuzhen Summit Held in Beijing BEIJING, Oct. 20, 2025 /PRNewswire/ — A news report from CRI Online: On… CISION PRNewswireOctober 20, 2025
